Малезија - Енглески - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

medispec (m) sdn.bhd - fluconazole -

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

peckforton pharmaceuticals ltd - paclitaxel - concentrate for solution for infusion - 6 milligram(s)/millilitre - taxanes; paclitaxel

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - aminolevulinic acid hydrochloride 10.2mg equivalent to aminolevulinic acid 8mg - dermal patch - 8 mg - active: aminolevulinic acid hydrochloride 10.2mg equivalent to aminolevulinic acid 8mg excipient: durotak 387-2353 scotchpak 1109 (baking film) pegoterate - treatment of mild to moderate actinic ketatoses (ak) lesions on the face and scalp.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

reckitt benckiser pty ltd - 37697 - compress, hot pack, chemical - a procedure pack consisting of nurofen gel (aust r 79909) and nurofen heat pack (artg 182074). the gel is indicated for temporary relief of pain and inflammation associated with acute soft tissue injuries including sprains, strains and sports injuries. the heat pack is indicated for effective pain relief of back and muscle pain - targets the pain by soothing muscle relaxing heat.

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

seacross pharmaceuticals ltd - pemetrexed disodium - powder for solution for infusion - 100mg

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

seacross pharmaceuticals ltd - pemetrexed disodium - powder for solution for infusion - 500mg

Израел - Енглески - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - film coated tablets - venetoclax 10 mg - venetoclax - chronic lymphocytic leukemia/small lymphocytic lymphomavenclexta in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll), who have received at least one prior therapy.venclexta in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).acute myeloid leukemiavenclexta in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (aml) who are ineligible for intensive chemotherapy.

Израел - Енглески - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - film coated tablets - venetoclax 100 mg - venetoclax - chronic lymphocytic leukemia/small lymphocytic lymphomavenclexta in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll), who have received at least one prior therapy.venclexta in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).acute myeloid leukemiavenclexta in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (aml) who are ineligible for intensive chemotherapy.

Израел - Енглески - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - film coated tablets - venetoclax 50 mg - venetoclax - chronic lymphocytic leukemia/small lymphocytic lymphomavenclexta in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll), who have received at least one prior therapy.venclexta in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).acute myeloid leukemiavenclexta in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (aml) who are ineligible for intensive chemotherapy.

Израел - Енглески - Ministry of Health

abbvie biopharmaceuticals ltd, israel - venetoclax - film coated tablets - venetoclax 10 mg - venetoclax - chronic lymphocytic leukemia/small lymphocytic lymphoma :venclexta in combination with rituximab or as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll), who have received at least one prior therapy.venclexta in combination with obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (cll) or small lymphocytic lymphoma (sll).acute myeloid leukemia :venclexta in combination with a hypomethylating agent or in combination with low dose cytarabine is indicated for newly diagnosed patients with acute myeloid leukemia (aml) who are ineligible for intensive chemotherapy.